Effects of subchronic treatments with SM-9018, a novel 5-HT2 and D2 antagonist, on dopamine and 5-HT receptors in rats-Reference-Cited by-同舟云学术

Effects of subchronic treatments with SM-9018, a novel 5-HT2 and D2 antagonist, on dopamine and 5-HT receptors in rats

Published:1995-10 Issue:6 Volume:19 Page:1091-1101
ISSN:0278-5846
Container-title:Progress in Neuro-Psychopharmacology and Biological Psychiatry
language:en
Short-container-title:Progress in Neuro-Psychopharmacology and Biological Psychiatry

Author:

Ohno Yukihiro,Ishibashi Tadashi,Okada Kana,Ishida Kumiko,Nakamura Mitsutaka

Publisher

Elsevier BV

Subject

Biological Psychiatry,Pharmacology

Reference34 articles.

1. Relationship of the actions of neuroleptic drugs to the pathophysiology of tardive dyskinesia;Baldessarini;Int. Rev. Neurobiol,1979

2. Neuroleptic-induced extrapyramidal side effects: clinical perspectives with ritanserin (R 55667), a new selective 5-HT2 receptor blocking agent;Bersani;Curr. Ther. Res.,1986

3. ffect of serotonin antagonism in schizophrenia: a pilot study with setoperone;Ceulemans;Psychopharmacology,1985

4. Repeated treatment with (−)-sulpiride plus a low dose of SCH 23390 displays wider neuroleptic activity without inducing dopaminergic supersensitivity;Dall'olio;Psychopharmacolgy,1990

5. Comparison of iprindole, imipramine and mianserin action on brain serotonergic and beta adrenergic receptors;Gandolfi;J. Pharmacol. Exp. Ther.,1984

Cited by 13 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Atypical antipsychotic properties of blonanserin, a novel dopamine D2 and 5-HT2A antagonist;Pharmacology Biochemistry and Behavior;2010-08

2. Anticataleptic 8-OH-DPAT preferentially counteracts with haloperidol-induced Fos expression in the dorsolateral striatum and the core region of the nucleus accumbens;Neuropharmacology;2008-10

3. A novel antipsychotic, perospirone, has antiserotonergic and antidopaminergic effects in human brain: findings from neuroendocrine challenge tests;Psychopharmacology;2004-05-25

4. 5-HT2A and 5-HT2C receptors and their atypical regulation properties;Life Sciences;2003-04

5. Perospirone;CNS Drugs;2001